Aurinia Pharmaceuticals, Inc. (AUPH)
15.73
-0.48
(-2.96%)
USD |
NASDAQ |
Nov 13, 16:00
15.72
0.00 (0.00%)
After-Hours: 19:59
Aurinia Pharmaceuticals Net Income (Quarterly) : 31.70M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 31.70M |
| June 30, 2026 | 37.41M |
| March 31, 2026 | 34.36M |
| December 31, 2025 | 210.79M |
| September 30, 2025 | 31.55M |
| June 30, 2025 | 21.51M |
| March 31, 2025 | 23.34M |
| December 31, 2024 | 1.429M |
| September 30, 2024 | 14.35M |
| June 30, 2024 | 0.722M |
| March 31, 2024 | -10.75M |
| December 31, 2023 | -26.88M |
| September 30, 2023 | -13.45M |
| June 30, 2023 | -11.49M |
| March 31, 2023 | -26.21M |
| December 31, 2022 | -26.05M |
| September 30, 2022 | -8.989M |
| June 30, 2022 | -35.52M |
| March 31, 2022 | -37.63M |
| December 31, 2021 | -33.32M |
| September 30, 2021 | -50.26M |
| June 30, 2021 | -47.01M |
| March 31, 2021 | -50.38M |
| December 31, 2020 | -8.074M |
| September 30, 2020 | -42.13M |
| Date | Value |
|---|---|
| June 30, 2020 | -26.54M |
| March 31, 2020 | -25.93M |
| December 31, 2019 | -76.47M |
| September 30, 2019 | -19.04M |
| June 30, 2019 | -15.90M |
| March 31, 2019 | -12.43M |
| December 31, 2018 | -14.59M |
| September 30, 2018 | -18.34M |
| June 30, 2018 | -15.71M |
| March 31, 2018 | -15.48M |
| December 31, 2017 | -3.332M |
| September 30, 2017 | -13.12M |
| June 30, 2017 | -2.399M |
| March 31, 2017 | -51.94M |
| December 31, 2016 | -8.333M |
| September 30, 2016 | -7.419M |
| June 30, 2016 | -3.276M |
| March 31, 2016 | -4.267M |
| December 31, 2015 | -4.063M |
| September 30, 2015 | -5.21M |
| June 30, 2015 | -0.733M |
| March 31, 2015 | -8.601M |
| December 31, 2014 | -4.919M |
| September 30, 2014 | -2.52M |
| June 30, 2014 | -11.03M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | -32.50M |
| Medicus Pharma Ltd. | -10.84M |
| Xenon Pharmaceuticals, Inc. | -110.44M |
| Psyence Biomedical Ltd. | -0.7533M |
| Agenus, Inc. | 1.567M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 83.70M |
| Total Expenses (Quarterly) | 52.00M |
| EPS Diluted (Quarterly) | 0.2345 |
| Enterprise Value | 1.680B |
| Gross Profit Margin (Quarterly) | 90.08% |
| Profit Margin (Quarterly) | 37.88% |
| Earnings Yield | 14.56% |
| Operating Earnings Yield | 6.73% |
| Normalized Earnings Yield | 14.56 |